Vir Biotechnology Inc. to Participate in TD Cowen 6th Annual Oncology Innovation Summit

Reuters
21 May
Vir Biotechnology Inc. to Participate in TD Cowen 6th Annual Oncology Innovation Summit

Vir Biotechnology Inc. will participate in the TD Cowen 6th Annual Oncology Innovation Summit on May 27. Marianne De Backer, Chief Executive Officer, and Mika Kakefuda Derynck, Executive Vice President, will engage in a virtual fireside chat at the event. A live webcast of the discussion will be accessible on the Vir Biotechnology website and archived for 30 days.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250520403573) on May 20, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10